The hidden risk of GLP-1 drugs

GLP-1 medications are increasingly being used by tens of millions of Americans, either currently or as a consideration. However, a hidden risk exists when patients experience rapid weight loss. This weight loss can lead to a reduction in muscle mass and bone density, thus increasing the risk of fractures and long-term mobility challenges.

To minimize these risks, patients must work closely with their doctors and incorporate exercise and strength training into their routines. GLP-1 medications function by mimicking glucagon-like peptide-1, a hormone that regulates blood sugar, appetite, and digestion, resulting in prolonged feelings of fullness and subsequent weight loss.

Within a year of therapy, patients can lose 5%-20% of their body weight, alongside significant improvements in cardiovascular health. Nevertheless, the weight loss process often involves shedding muscle and bone, with roughly 25% of total weight loss attributed to changes in musculoskeletal mass. This can potentially elevate the risk of fractures, particularly in older adults.

While comprehensive data on fractures among GLP-1 users remains scarce, research indicates an 11% heightened fracture risk in older adults with type 2 diabetes using these medications. Older women and those in perimenopause could be especially susceptible, as menopause-induced estrogen decline may result in 10-20% bone mineral density loss.

The combination of GLP-1 use and menopause can worsen these losses. Although these medications are not off-limits for older patients or those seeking benefits beyond weight loss, they must remain vigilant about secondary effects and collaborate with their physicians to implement mitigation strategies. Patients should have an in-depth discussion with their doctors about the advantages and risks of GLP-1s, particularly if they are otherwise healthy and seek the medications primarily for cosmetic reasons.

A treatment plan focusing on exercise and strength training is crucial, as such a regimen can aid in weight loss while preserving bone and muscle health. Strength training is particularly effective in promoting bone growth and potentially enhancing bone mineral density. Proper nutrition is also essential, necessitating diets rich in protein, calcium, vitamin D, and magnesium to support muscle and bone health.

Despite their remarkable efficacy, GLP-1 drugs can provide health benefits beyond weight loss and diabetes management, such as improved cardiovascular health and potential advantages for kidney disorders, osteoarthritis, and addiction. Consequently, it is crucial for patients to understand both the advantages and drawbacks of these medications and to work closely with their doctors to maintain their long-term muscle strength and bone health while still achieving their weight loss goals.